INTRODUCTION: The purpose of this study was to measure and analyze motor unit number estimation (MUNE) values longitudinally in spinal muscular atrophy (SMA). METHODS: Sixty-two children with SMA types 2 and 3 were observed prospectively for up to 42 months. Longitudinal electrophysiological data were collected, including compound motor action potential (CMAP), single motor unit action potential (SMUP), and MUNE. RESULTS: Significant motor neuron loss and compensatory collateral reinnervation were noted at baseline. Over time, there was a significant mean increase in MUNE (4.92 units/year, P = 0.009), a mean decrease in SMUP amplitude (-6.32 μV/year, P = 0.10), and stable CMAP amplitude. CONCLUSIONS: The unexpected longitudinal results differ from findings in amyotrophic lateral sclerosis studies, perhaps indicating that compensatory processes in SMA involve new motor unit development. A better understanding of the mechanisms of motor unit decline and compensation in SMA is important for assessing novel therapeutic strategies and for providing key insights into disease pathophysiology.
INTRODUCTION: The purpose of this study was to measure and analyze motor unit number estimation (MUNE) values longitudinally in spinal muscular atrophy (SMA). METHODS: Sixty-two children with SMA types 2 and 3 were observed prospectively for up to 42 months. Longitudinal electrophysiological data were collected, including compound motor action potential (CMAP), single motor unit action potential (SMUP), and MUNE. RESULTS: Significant motor neuron loss and compensatory collateral reinnervation were noted at baseline. Over time, there was a significant mean increase in MUNE (4.92 units/year, P = 0.009), a mean decrease in SMUP amplitude (-6.32 μV/year, P = 0.10), and stable CMAP amplitude. CONCLUSIONS: The unexpected longitudinal results differ from findings in amyotrophic lateral sclerosis studies, perhaps indicating that compensatory processes in SMA involve new motor unit development. A better understanding of the mechanisms of motor unit decline and compensation in SMA is important for assessing novel therapeutic strategies and for providing key insights into disease pathophysiology.
Authors: Kathryn J Swoboda; Thomas W Prior; Charles B Scott; Teresa P McNaught; Mark C Wride; Sandra P Reyna; Mark B Bromberg Journal: Ann Neurol Date: 2005-05 Impact factor: 10.422
Authors: E Mercuri; E Bertini; S Messina; A Solari; A D'Amico; C Angelozzi; R Battini; A Berardinelli; P Boffi; C Bruno; C Cini; F Colitto; M Kinali; C Minetti; T Mongini; L Morandi; G Neri; S Orcesi; M Pane; M Pelliccioni; A Pini; F D Tiziano; M Villanova; G Vita; C Brahe Journal: Neurology Date: 2006-11-02 Impact factor: 9.910
Authors: Laurent P Bogdanik; Melissa A Osborne; Crystal Davis; Whitney P Martin; Andrew Austin; Frank Rigo; C Frank Bennett; Cathleen M Lutz Journal: Proc Natl Acad Sci U S A Date: 2015-10-12 Impact factor: 11.205
Authors: Vicki L McGovern; Chitra C Iyer; W David Arnold; Sara E Gombash; Phillip G Zaworski; Anton J Blatnik; Kevin D Foust; Arthur H M Burghes Journal: Hum Mol Genet Date: 2015-07-23 Impact factor: 6.150
Authors: Laura H Comley; Rachel A Kline; Alison K Thomson; Victoria Woschitz; Eric Villalón Landeros; Erkan Y Osman; Christian L Lorson; Lyndsay M Murray Journal: Hum Mol Genet Date: 2022-09-10 Impact factor: 5.121
Authors: W Arnold; Vicki L McGovern; Benjamin Sanchez; Jia Li; Kaitlyn M Corlett; Stephen J Kolb; Seward B Rutkove; Arthur H Burghes Journal: Neurobiol Dis Date: 2015-12-28 Impact factor: 5.996
Authors: Basil T Darras; Claudia A Chiriboga; Susan T Iannaccone; Kathryn J Swoboda; Jacqueline Montes; Laurence Mignon; Shuting Xia; C Frank Bennett; Kathie M Bishop; Jeremy M Shefner; Allison M Green; Peng Sun; Ishir Bhan; Sarah Gheuens; Eugene Schneider; Wildon Farwell; Darryl C De Vivo Journal: Neurology Date: 2019-04-24 Impact factor: 9.910
Authors: Catherine D McCusker; Antony Athippozhy; Carlos Diaz-Castillo; Charless Fowlkes; David M Gardiner; S Randal Voss Journal: BMC Dev Biol Date: 2015-11-23 Impact factor: 1.978